$CRSP

$51.49 +$2.48 (5.06%) Live

$CRSP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 96.7M shares outstanding

Who owns CRSP?

By type of holder

Institutions 78.3% Insiders 14.2% Everyone else 7.6%

Concentration Top 10 holders own 57.1%

George Simeon 13.5% · ARK Investment Management LLC 9.8%

Institutional ownership

78.3%

-1.5 pts vs last qtr

Institutional holders

517

+25 vs last qtr

Net shares bought

−1.5M

by institutions in Q2 2026

New / sold out

80 / 55

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

D. E. Shaw & Co., Inc. NEW +893.8K
BlackRock, Inc. +668.9K

Biggest sellers in Q2 2026

ARK Investment Management LLC −1.9M
Loomis Sayles & Co L P SOLD OUT −968.1K

Who is planning to sell?

Notices of proposed sale, last 12 months

$11.9M

9 notices from 5 people

Shares covered

205.3K

0.21% of the company

Arranged in advance

87%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Samarth Kulkarni Officer 10b5-1 $5.23M
Raju Prasad Officer 10b5-1 $4.45M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2017–FY2025

+124.5%

+10.64% a year

Each share's claim on the business

−55.5%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$57K vs $604M

over 9 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years59% 3–5 years8% 1–3 years16% Under 1 year17%

Quarterly turnover

9.0%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting CRSP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AI ARK Investment Management LLC	9.5M	9.78%	−1.9M (−16.4%)	≤2021	3.4%
Shares held by quarter Peak holding11.3M (Q1'26) Change over 8 quarters+2.0M Share of the company9.780% ARK Investment Management LLC's full portfolio →
B BlackRock, Inc.	8.3M	8.63%	+668.9K (+8.7%)	≤2021	0.0%
Shares held by quarter Peak holding8.3M (Q2'26) Change over 8 quarters+5.6M Share of the company8.630% BlackRock, Inc.'s full portfolio →

ARK Investment Management LLC

9.5M

% of company

9.78%

Change vs last qtr

−1.9M (−16.4%)

Held since

≤2021

BlackRock, Inc.

8.3M

% of company

8.63%

Change vs last qtr

+668.9K (+8.7%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding CRISPR Therapeutics AG, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CRSP on Form N-PORT; together they hold 2.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$60.4M	1.1M	1.14%	0.06%	June 30, 2026
VR Vanguard Russell 2000 Index Fund Vanguard Scottsdale Funds	$26.4M	469.2K	0.49%	0.15%	May 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$60.4M

% of company

1.14%

% of the fund

0.06%

As of

June 30, 2026

Vanguard Russell 2000 Index Fund

Vanguard Scottsdale Funds

Position value

$26.4M

% of company

0.49%

% of the fund

0.15%

As of

May 31, 2026

23 more funds behind a free account

See every fund holding CRISPR Therapeutics AG and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
GS George Simeon Insider	13.1M	13.54%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company13.540% George Simeon's insider activity →
KS Kulkarni Samarth Insider	397.5K	0.41%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.410% Kulkarni Samarth's insider activity →

George Simeon

Insider

13.1M

% of company

13.54%

Change vs last qtr

—

Held since

—

Kulkarni Samarth

Insider

397.5K

% of company

0.41%

Change vs last qtr

—

Held since

—

8 more holders behind a free account

See every insider and 5%+ holder of CRISPR Therapeutics AG.

Comments